Lighter Periods: Heavy periods are common in women with a higher body weight
Clinicians must therefore rely on general safety data, pharmacologic principles, and individualized clinical judgment when prescribing semaglutide to these patients
Frequently, that means designing different molecules to target the same pathway or related biological mechanism
Researchers from the Mills-Peninsula Medical Center, Stanford University, the University of Miami, Thomas Jefferson University and the Diabetes Technology Society partnered with data company Atropos Health and used artificial intelligence (AI) to analyze millions of anonymous patient records from when GLP-1s were first introduced in January 2015 to April 2023
Searches were performed in PubMed, ScienceDirect, and Google Scholar for publications between 1 January 2000 and 31 March 2025, using Boolean operators to combine terms such as (GLP-1 receptor agonist OR GLP-1 RA OR semaglutide OR liraglutide OR dulaglutide OR exenatide OR tirzepatide) AND (smoking cessation OR nicotine dependence OR nicotine addiction OR tobacco use disorder), as well as (GLP-1 receptor agonist OR GLP-1 RA) AND (weight gain OR obesity OR weight management OR post-cessation weight gain)
(D) MDPP suppliers must ensure that MDPP beneficiaries engage with and understand the content of each Online session